ScoreWhy is Coherus BioSciences, Inc. ?
1
The company declared very negative results in Mar'25 after negative results in Dec'24
- NET SALES(Q) At USD 10.25 MM has Fallen at -79.23%
- PRE-TAX PROFIT(Q) At USD -44.86 MM has Fallen at -75.13%
- NET PROFIT(Q) At USD -44.86 MM has Fallen at -75.13%
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 5.79%, its profits have fallen by -97.3%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Coherus BioSciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Coherus BioSciences, Inc.
-28.07%
-0.30
88.97%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-21.77%
EBIT Growth (5y)
-191.87%
EBIT to Interest (avg)
-5.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.17
Sales to Capital Employed (avg)
1.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
92.65%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.52
EV to EBIT
-2.88
EV to EBITDA
-3.01
EV to Capital Employed
10.09
EV to Sales
1.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-350.73%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-30What is not working for the Company
NET SALES(Q)
At USD 10.25 MM has Fallen at -79.23%
PRE-TAX PROFIT(Q)
At USD -44.86 MM has Fallen at -75.13%
NET PROFIT(Q)
At USD -44.86 MM has Fallen at -75.13%
ROCE(HY)
Lowest at -860.65%
RAW MATERIAL COST(Y)
Grown by 19.91% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.66 times
OPERATING PROFIT(Q)
Lowest at USD -44.47 MM
Here's what is not working for Coherus BioSciences, Inc.
Net Sales
At USD 10.25 MM has Fallen at -79.23%
over average net sales of the previous four periods of USD 49.37 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -44.86 MM has Fallen at -75.13%
over average net sales of the previous four periods of USD -25.62 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -44.86 MM has Fallen at -75.13%
over average net sales of the previous four periods of USD -25.62 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -44.47 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Debtors Turnover Ratio
Lowest at 0.66 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 19.91% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
